|
Enlarge font
Reduce font
Can-Fite recruits patients for hepatitis C study
Can-Fite is also recruiting patients for a Phase I/II clinical trial for CF102 for treating liver cancer.
Globes' correspondent14 Jul 09 11:31
For the whole article please click here.
|
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
feeds
HomeMarket prices | Site map | Newsletters | Israel links | About us | Support | Report Faults | Advertise | Archive | 
Home | News | Analysis | Features | Technology guide | Real estate | Israel in depth | International
Application delivery by 